Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

C.I. Pigment red 221

Product Specifications

UNSPSC Description

C.I. Pigment red 221 is the most important colorant used to add color or change the color of something and is chemically essentially unaffected by the carrier or medium into which it is incorporated. It can be widely used in textile, medicine, food, cosmetics, plastics, paint, ink, photography and paper industries.

Target Antigen

Fluorescent Dye

Type

Dye Reagents

Related Pathways

Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/c-i-pigment-red-221.html

Solubility

10 mM in DMSO

Smiles

OC1=C(C2=CC=CC=C2C=C1C(NC(C=C(Cl)C(NC(C3=CC4=CC=CC=C4C(N=NC5=CC(C(OC(C)C)=O)=CC=C5C)=C3O)=O)=C6)=C6Cl)=O)N=NC7=CC(C(OC(C)C)=O)=CC=C7C

Molecular Weight

925.81

References & Citations

[1]Gürses A, Açıkyıldız M, Güneş K, et al. Dyes and pigments: their structure and properties[J]. Dyes and pigments, 2016: 13-29.

Shipping Conditions

Room temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-D0686/C-I-Pigment-red-221-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-D0686/

Clinical Information

No Development Reported

CAS Number

71566-54-6

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

JBJ-04-125-02
558957 500.0mg

JBJ-04-125-02

Ask
View Details
2-Bromo-2'-hydroxyacetophenone Oxime
MBS6017051-01 250 mg

2-Bromo-2'-hydroxyacetophenone Oxime

Ask
View Details
2-Bromo-2'-hydroxyacetophenone Oxime
MBS6017051-02 5x 250 mg

2-Bromo-2'-hydroxyacetophenone Oxime

Ask
View Details
Cuzd1 siRNA Oligos set (Mouse)
17149174 3 x 5 nmol

Cuzd1 siRNA Oligos set (Mouse)

Ask
View Details
MAD3 (MXD3) (NM_031300) Human Over-expression Lysate
LS083463 100 µg

MAD3 (MXD3) (NM_031300) Human Over-expression Lysate

Ask
View Details
Tom1L-1 (3F12) FITC
sc-130565 FITC 200 µg/mL

Tom1L-1 (3F12) FITC

Ask
View Details